Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03867084 |
|---|---|
| Brief Title: | Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937) |
| First Submitted : | March 6, 2019 |
| First Submitted that Met QC Criteria : | March 6, 2019 |
| First Posted : | March 7, 2019 |
| Last Update Submitted that Met QC Criteria : | December 23, 2022 |
| Last Update Posted : | December 27, 2022 |